Introduction
Nucleus pulposus (NP) replacement offers a novel therapy for degenerative disc disease (DDD). Previously a novel polyurethane scaffold (PUS) and a fibrinogen-hyaluronic acid (FBG-HA) conjugate based hydrogel were developed. 1, 2 The aim of this ex vivo study (EVS) was to evaluate the regenerative potential of the PUS and the FBG-HA hydrogel with/without transglutaminase (TG) crosslinked bone morphogenetic protein (BMP)-2/7 heterodimer in an organ culture system (OCS). Additionally an in vitro study (IVS) was conducted to evaluate the anabolic stimulus and biocompatibility of FBG-HA conjugate cell constructs containing different concentrations of covalently bound BMP-2/7.
Material and Methods

IVS:
Bovine NP cells were seeded into FBG-HA conjugate hydrogel beads at 1.2x10 5 cells per bead (4x10 6 cells/ml). Each bead was prepared by suspending 1.2x10 5 NP cells in 20µl of FBG-HA conjugate. Finally 10µl of thrombin (5.2 U/ml) containing 0, 1000, or 5000 ng/ml TG-BMP-2/7 were added (n = 6/group). Beads were cultured for 7 or 14 days. Conditioned medium was collected for biochemical analysis. Gene expression was analyzed and DNA-and GAG content of the samples was measured. For the EVS, discoid/ravioli shape PUS were manufactured as previously described [1, 2] . Bovine IVDs with endplates were nucleotomized and refilled with either (1) PUS, (2) PUS surrounded by 50-80 µl FBG-HA or (3) PUS surrounded by 50-80µl FBG-HA containing 5000 ng/ml TG-BMP-2/7 (n = 8/group). Empty discs served as controls. Biomaterials were evaluated in an OCS under dynamic load for 14 days at 0-0.1 MPa, 0.1 Hz for 3 hour/day. Disc height was recorded after load and recovery at day 1, 7 and 14. Disc tissue was harvested after 14 days and gene expression was analyzed. GAG and Collagen-content of the disc tissue was assessed and Proteoglycan synthesis was analyzed by Sulfur-35 ( 35 S) incorporation measurement. Histology was performed using Safranin O/Fast Green staining. One-way ANOVA was used to determine statistical significance.
Results
IVS:
A trend of higher Aggrecan expression in hydrogels with 5000 ng/mL of TG-BMP-2/7 was observed on day 7 compared with hydrogels without (p = 0.065) and with 1000 ng/mL (p = 0.067) of TG-BMP-2/7. On day 14, there was a trend of higher Collagen 2 expression in hydrogels with 5000ng/mL of TG-BMP-2/7 compared with hydrogels without (p = 0.085) and 1000 ng/mL (p = 0.053) of TG-BMP-2/7. GAG/DNA ratio was significantly higher in NP cell-seeded FBG-HA hydrogels containing 1000ng/ml and 5000ng/ml TG-BMP-2/7 compared with control after 7 days. EVS: All 3 implant groups maintained their disc height after dynamic load, while it dropped by 7% in empty controls (p < 0.001 versus implant groups). When FBG-HA hydrogel containing TG-BMP-2/7 was implanted, the gene expression of Aggrecan in NP tissue increased 4.5-fold (p = 0.083). GAG/DNA ratio increased by 46% in the remaining NP tissue when TG-BMP-2/7 was applied (p = 0.113).
Conclusion
The PUS is able to restore the disc height of nucleotomized discs; addition of FBG-HA hydrogel does not affect the swelling capacity of the PUS in situ. Due to their stimulation of anabolic gene expression and production of NP ECM components the FBG-HA hydrogel and TG-BMP2/7 may support biological repair of NP tissue.
